Frontage Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Frontage Laboratories Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5163
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Frontage Laboratories Inc (Frontage), a subsidiary of Hangzhou Tigermed Consulting Co Ltd is a contract research organization that offers early phase drug development and other research services. The organization’s services include clinical research, drug metabolism and pharmacokinetic, CMC services, bioanalytical, agrochemical services, and GMP consulting services. Its DMPK services include in vitro absorption, distribution, metabolism, and excretion studies, in vivo ADME studies, metabolite identification, non-GLP bioanalytical studies, radiolabeled studies and metabolites in safety testing for clinical compounds. Frontage’s CMC product development services includes organic synthesis, pharmaceutical formulation development, GMP analytical testing and GMP clinical trial material manufacturing. The organization caters to pharmaceutical and biotech companies. It has presence in China and the US. Frontage is headquartered in Exton, Pennsylvania, the US.

Frontage Laboratories Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Frontage Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Frontage Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 9
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Zhejiang Jiuzhou Pharma forms Joint Venture with Frontage Labs 11
Acquisition 12
Frontage Laboratories Acquires Concord Biosciences 12
Hangzhou Tigermed Completes Acquisition of Majority Stake in Frontage Labs for USD50.2 Million 13
Frontage Laboratories Inc – Key Competitors 14
Frontage Laboratories Inc – Key Employees 15
Frontage Laboratories Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 17
Recent Developments 18
Strategy And Business Planning 18
Mar 13, 2018: Frontage announces expansion into Princeton, NJ 18
Corporate Communications 19
May 03, 2018: Frontage Appoints Hugh Davis as Chief Business Officer 19
Mar 15, 2017: Frontage Announces that Dr. Philip Doren has Joined Frontage as the President of Clinical Services 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts 2
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Frontage Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Frontage Laboratories Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Frontage Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 9
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Zhejiang Jiuzhou Pharma forms Joint Venture with Frontage Labs 11
Frontage Laboratories Acquires Concord Biosciences 12
Hangzhou Tigermed Completes Acquisition of Majority Stake in Frontage Labs for USD50.2 Million 13
Frontage Laboratories Inc, Key Competitors 14
Frontage Laboratories Inc, Key Employees 15
Frontage Laboratories Inc, Other Locations 16
Frontage Laboratories Inc, Subsidiaries 16
Frontage Laboratories Inc, Joint Venture 17

List of Figures
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Frontage Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Frontage Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Airlines Ltd.:企業の戦略・SWOT・財務情報
    China Airlines Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Oaktree Capital Group LLC:企業の戦略・SWOT・財務情報
    Oaktree Capital Group LLC - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Elixir Energy Ltd (EXR):企業の財務・戦略的SWOT分析
    Summary Elixir Energy Ltd (Elixir Energy) is an independent oil and gas exploration and production company that acquires, explores, and develops conventional and unconventional oil and gas properties. The company's projects include Petra project, Wattenberg project, and Moselle Permit. Its Petra pro …
  • Cisco Systems, Inc.:企業のM&A・事業提携・投資動向
    Cisco Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cisco Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Altona Energy Plc:企業の戦略・SWOT・財務分析
    Altona Energy Plc - Strategy, SWOT and Corporate Finance Report Summary Altona Energy Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • If P&C Insurance AS:企業の戦略・SWOT・財務分析
    If P&C Insurance AS - Strategy, SWOT and Corporate Finance Report Summary If P&C Insurance AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mangalore Refinery and Petrochemicals Ltd (MRPL):企業の財務・戦略的SWOT分析
    Mangalore Refinery and Petrochemicals Ltd (MRPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Profarma Distribuidora de Produtos Farmaceuticos SA (PFRM3):企業の財務・戦略的SWOT分析
    Profarma Distribuidora de Produtos Farmaceuticos SA (PFRM3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • Synlogic Inc (SYBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Synlogic Inc (Synlogic), formerly TMC Therapeutics Inc is a clinical stage drug development company that develops novel class of living medicines for the treatment of rare and genetic metabolic diseases, by applying synthetic biology to probiotics. The company’s pipeline includes SYNB1020 a …
  • Stealth BioTherapeutics Corp (MITO):企業の戦略的SWOT分析
    Stealth BioTherapeutics Corp (MITO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Cooperativa Muratori & Cementisti C.M.C di Ravenna:企業の戦略・SWOT・財務情報
    Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report Summary Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • PNM Resources Inc (PNM):企業の財務・戦略的SWOT分析
    PNM Resources Inc (PNM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • C&S Wholesale Grocers, Inc.
    C&S Wholesale Grocers, Inc. - Strategy, SWOT and Corporate Finance Report Summary C&S Wholesale Grocers, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Interface Biologics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in blood contacting medical devices and polyme …
  • First Data Corp (FDC):企業の財務・戦略的SWOT分析
    First Data Corp (FDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Icahn Enterprises LP:企業のM&A・事業提携・投資動向
    Icahn Enterprises LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Icahn Enterprises LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Alstom SA (ALO)-エネルギー分野:企業M&A・提携分析
    Summary Alstom SA (Alstom) is a manufacturer of transportation vehicles. It designs, develops and manufactures rail transport equipment, systems, services and signaling for urban, suburban, regional and main line passenger transportation, and for freight transportation. The company offers a wide ran …
  • Kvaerner ASA (KVAER):企業の財務・戦略的SWOT分析
    Kvaerner ASA (KVAER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • National Australia Bank Group Ltd:戦略・SWOT・企業財務分析
    National Australia Bank Group Ltd - Strategy, SWOT and Corporate Finance Report Summary National Australia Bank Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆